Donor activating KIR2DS1 in leukemia.

Autor: Venstrom JM; University of California, San Francisco, San Francisco, CA., Dupont B, Hsu KC, Pittari G, Gooley TA, Chewning JH, Spellman S, Haagenson M, Gallagher MM, Malkki M, Petersdorf E
Jazyk: angličtina
Zdroj: The New England journal of medicine [N Engl J Med] 2014 Nov 20; Vol. 371 (21), pp. 2042.
DOI: 10.1056/NEJMc1411443
Databáze: MEDLINE